Arkolith/Insider Trading/TPTX/Form 4

North Annette

EVP, General Counsel & Secty.Turning Point Therapeutics, Inc. (TPTX) · full profile →Form 4 · filed May 7, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2021Option exercise(M)6K$17.00$100K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 6, 2021Option exercise(M)6K—$0170K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-030925) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML